CD2665
CAS: 170355-78-9
Ref. TM-T14911
| 1mg | 89.00 € | ||
| 5mg | 161.00 € | ||
| 10mg | 235.00 € | ||
| 25mg | 395.00 € | ||
| 50mg | To inquire | ||
| 1mL*10mM (DMSO) | 185.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
Product Information
Name:
CD2665
Synonyms:
- CD-2665
- Cd 2665
- 4-(6-((2-Methoxyethoxy)methoxy)-7-tricyclo(3.3.1.1.3,7)dec-1-yl-2-naphthalenyl)Benzoic acid
- Cd2665
- Benzoic acid, 4-(6-((2-methoxyethoxy)methoxy)-7-tricyclo(3.3.1.1.3,7)dec-1-yl-2-naphthalenyl)-
- 4-{6-[(2-Methoxyethoxy)Methoxy]-7-(Tricyclo[3.3.1.1~3,7~]Dec-1-Yl)Naphthalen-2-Yl}Benzoic Acid
Description:
CD2665 is an orally active antagonist of retinoic acid receptor (RAR). For RARγ and RARβ, the Kis are 110 nM and 306 nM.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
486.6
Formula:
C31H34O5
Purity:
99.67%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T14911 CD2665
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
